IP Library Granted Patent US 12,359,234
Granted Patent B2
US 12,359,234 · App. 17/634,392 · Granted Jul 15, 2025

Oligosaccharide production in yeast cells expressing an ABC transporter protein

Inventors: Jessica Walter (Emeryville, CA); Dominic Pinel (Emeryville, CA)
Assignee: Amyris, Inc.
C12P19/04C12Y101/01271C12Y204/01069C12Y204/01152C12Y204/99004C12Y205/01057C12Y207/07023C12Y207/07043C12Y306/03C12Y402/01047C12Y501/03014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,359,234
App. No.
17/634,392
Granted
Jul 15, 2025
Kind
B2
Abstract

Provided herein are genetically modified yeast cells capable of producing one or more human milk oligosaccharides (HMOs) and methods of making such cells. The yeast cells are engineered to comprise a heterologous nucleic acid encoding a transporter protein and one or more heterologous nucleic acids that encode enzymes of a HMO biosynthetic pathway. Also provided are fermentation compositions including the disclosed genetically modified yeast cells, and related methods of producing and recovering HMOs generated by the yeast cells.

Claims (10)

1. A yeast cell genetically modified to produce one or more human milk oligosaccharides, wherein the yeast cell comprises (i) a heterologous nucleic acid encoding a human milk oligosaccharide (HMO) ABC transporter polypeptide; and (ii) one or more heterologous nucleic acids that each independently encode at least one enzyme of a human milk oligosaccharide biosynthetic pathway.

2. The yeast cell of claim 1 , wherein the ABC transporter exports the human milk oligosaccharide 2′-fucosyllactose.

3. The yeast cell of claim 1 , wherein the ABC transporter has at least 95% identity to any one of SEQ ID NOS: 1-27.

4. The yeast cell of claim 3 , wherein the ABC transporter has at least 95% identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3.

5. The yeast cell of claim 1 , wherein the one or more human milk oligosaccharides comprise 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, 3′-sialyllactose, 6′-sialyllactose, and/or difucosyllactose.

6. The yeast cell of claim 5 , wherein the enzymes encoded by the one or more heterologous nucleic acids that independently encode at least one enzyme of the human milk oligosaccharide biosynthetic pathway comprise one or more of a GDP-mannose 4,6-dehydratase, a GDP-L-fucose synthase, an α-1,2-fucosyltransferase, a fucosidase, β-1,3-N-acetylglucosaminyltransferase, a β-1,3-galactosyltransferase, a UDP-N-acetylglucosamine diphosphorylase, a β-1,4-galactosyltransferase, a CMP-Neu5Ac synthetase, a sialic acid synthase, a UDP-N-acetylglucosamine 2-epimerase, a CMP-N-acetylneuraminate-β-galactosamide-α-2,3-sialyltransferase, and an α-1,3-fucosyltransferase.

7. The yeast cell of claim 1 , wherein the enzymes encoded by the one or more heterologous nucleic acids further comprise a protein that transports lactose into the yeast cell.

8. A method of producing one or more human milk oligosaccharides, the method comprising culturing a population of genetically modified yeast cells of claim 1 in a culture medium under conditions suitable for the yeast cells to produce the one or more human milk oligosaccharides.

9. A fermentation composition comprising:

a population of genetically modified yeast cells comprising the yeast cell of claim 1 ; and a culture medium comprising one or more human milk oligosaccharides produced from the yeast cells.

Assignments (6)
SECURITY INTEREST Recorded Oct 6, 2025
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 072483/0112 →
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2022
From: WALTER, JESSICA; PINEL, DOMINIC
To: AMYRIS, INC.
Reel/Frame 059913/0143 →